The cut-off for estrogen and progesterone receptor in endometrial cancer revisited: an ENITEC collaboration study. Jan van Weelden W, Reijnen C, Kusters-Vandevelde HVN, Bulten J, et al. Hum Pathol 2020 Dec 15. pii: S0046-8177(20)30255.

Read + Share

Amedeo Smart

Independent Medical Education

Jan van Weelden W, Reijnen C, Kusters-Vandevelde HVN, Bulten J, et al. The cut-off for estrogen and progesterone receptor in endometrial cancer revisited: an ENITEC collaboration study. Hum Pathol 2020 Dec 15. pii: S0046-8177(20)30255.
PMID: 33338506